A manufacturer-funded study found a significant decrease in annual total medical costs in patients with overweight/obesity ...
Novo Nordisk, which manufactures weight-loss drug Wegovy and diabetes medication Ozempic, has asked the US authorities to ...
The sizeable new round follows the announcement of phase 1 data for its lead asset MET-097i in September, and according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback